EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches

Marie-France Bellin, Catarina Valente, Omar Bekdache, Florian Maxwell, Cristina Balasa, Alexia Savignac, Olivier Meyrignac

Cancers · 18.05.2024 · 16 (10) · 1926

DOI: 10.3390/cancers16101926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.05.2024. Verfasst von Marie-France Bellin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Radiologie Diagnostique et Interventionnelle, Hôpital de Bicêtre AP-HP, 78 Rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review highlights recent advances in renal cell carcinoma (RCC) imaging. It begins with dual-energy computed tomography (DECT), which has demonstrated a high diagnostic accuracy in the evaluation of renal masses. Several studies have suggested the potential benefits of iodine quantification, particularly for distinguishing low-attenuation, true enhancing solid masses from hyperdense cysts. By determining whether or not a renal mass is present, DECT could avoid the need for additional imaging studies, thereby reducing healthcare costs. DECT can also provide virtual unenhanced images, helping to reduce radiation exposure. The review then provides an update focusing on the advantages of multiparametric magnetic resonance (MR) imaging performance in the histological subtyping of RCC and in the differentiation of benign from malignant renal masses. A proposed standardized stepwise reading of images helps to identify clear cell RCC and papillary RCC with a high accuracy. Contrast-enhanced ultrasound may represent a promising diagnostic tool for the characterization of solid and cystic renal masses. Several combined pharmaceutical imaging strategies using both sestamibi and PSMA offer new opportunities in the diagnosis and staging of RCC, but their role in risk stratification needs to be evaluated. Although radiomics and tumor texture analysis are hampered by poor reproducibility and need standardization, they show promise in identifying new biomarkers for predicting tumor histology, clinical outcomes, overall survival, and the response to therapy. They have a wide range of potential applications but are still in the research phase. Artificial intelligence (AI) has shown encouraging results in tumor classification, grade, and prognosis. It is expected to play an important role in assessing the treatment response and advancing personalized medicine. The review then focuses on recently updated algorithms and guidelines. The Bosniak classification version 2019 incorporates MRI, precisely defines previously vague imaging terms, and allows a greater proportion of masses to be placed in lower-risk classes. Recent studies have reported an improved specificity of the higher-risk categories and better inter-reader agreement. The clear cell likelihood score, which adds standardization to the characterization of solid renal masses on MRI, has been validated in recent studies with high interobserver agreement. Finally, the review discusses the key imaging implications of the 2017 AUA guidelines for renal masses and localized renal cancer.

Schlagwörter

Stichwörter der Autor:innen

AUA guidelinesBosniak classification version 2019PSMA PET/CTartificial intelligenceclear cell likelihood scorecontrast-enhanced ultrasounddual-energy CTmultiparametric MRIphoton-counting detector CTquantitative computed tomographyradiomicsrenal cell carcinomasestamibi SPECT/CTspectral CT

Autor:innen und Institutionen

  • Service de Radiologie Diagnostique et Interventionnelle, Hôpital de Bicêtre AP-HP, 78 Rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France.
  • Faculté de Médecine, University of Paris-Saclay, 63 Rue Gabriel Péri, 94276 Le Kremlin-Bicêtre, France.
  • BioMaps, UMR1281 INSERM, CEA, CNRS, University of Paris-Saclay, 94805 Villejuif, France.

Zitieren

APA

Bellin, M. F., Valente, C., Bekdache, O., Maxwell, F., Balasa, C., Savignac, A., & Meyrignac, O. (2024). Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches. Cancers, 16(10), 1926. https://doi.org/10.3390/cancers16101926

Vancouver

Bellin MF, Valente C, Bekdache O, Maxwell F, Balasa C, Savignac A, et al. Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches. Cancers. 2024;16(10):1926. doi:10.3390/cancers16101926

BibTeX
@article{Bellin2024,
  author = {Bellin, Marie-France and Valente, Catarina and Bekdache, Omar and Maxwell, Florian and Balasa, Cristina and Savignac, Alexia and Meyrignac, Olivier},
  title = {Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1926},
  doi = {10.3390/cancers16101926}
}
Kostenlos starten →